There are currently no drugs specifically approved for the treatment of insulin resistance, but various studies have demonstrated the efficacy of certain antidiabetic drugs in improving insulin resistance [1], such as glucagon‐like peptide‐1 (GLP‐1) receptor agonists (GLP‐1RA) [4]. Here, GLP1R is linked to Insulin resistance.